A report, funded by the pharmaceutical lobby, shows that pharmacy benefit managers are making drugmakers compete to keep prices in check, says Pharmaceutical Care Management Association President and CEO Mark Merritt. “[P]ayers have been demanding and getting bigger and bigger discounts and rebates as drug prices rise,” Merritt said, adding that disclosing specific information on rebates would undermine competition.